STOCK TITAN

Cronos Group (CRON) Stock News

CRON Nasdaq

Welcome to our dedicated page for Cronos Group news (Ticker: CRON), a resource for investors and traders seeking the latest updates and insights on Cronos Group stock.

Cronos Group Inc. reports developments for a global cannabis and cannabinoid company focused on consumer goods, cannabis research, technology and product development. Its brand portfolio includes Spinach®, PEACE NATURALS®, LIT® and Lord Jones®, with news often centered on product innovation across Canadian cannabis formats such as pre-rolls and vapes.

Recurring Cronos updates also cover operating and financial results, earnings conference calls, annual shareholder meetings, proxy and governance matters, capital-structure disclosures and public-company presentations. The company’s disclosures connect brand launches and R&D-driven product development with the financial and governance reporting of a Nasdaq- and TSX-listed cannabis issuer.

Rhea-AI Summary

Cronos (NASDAQ: CRON; TSX: CRON) will hold its 2025 fourth quarter and full-year earnings conference call on Thursday, February 26, 2026 at 8:30 a.m. ET.

Senior management will discuss financial results and take investor questions after prepared remarks. Registration and webcast access are available via the company’s investor website, and the webcast will be archived for replay.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.53%
Tags
conferences
-
Rhea-AI Summary

Cronos Group (NASDAQ: CRON) launched its premium Lord Jones cannabis brand in Israel on February 2, 2026, introducing five indoor-grown flower strains to the Israeli medical market.

The rollout emphasizes small-batch indoor cultivation, cold-cure processing, hand trimming and glass jar packaging, and will expand with special editions and limited-run products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Cronos (NASDAQ: CRON) announced on December 9, 2025 that a wholly‑owned subsidiary signed a definitive agreement to acquire CanAdelaar B.V., the largest company in the Netherlands’ adult‑use cannabis pilot (Wietexperiment).

Up‑front consideration is €57.5 million (US$67.0 million), roughly 1.4x LTM revenue and 2.4x LTM EBITDA, with an additional cash earnout equal to 0.5x normalized EBITDA in 2026 and 2027. Cronos said the deal will deliver a #1 market share in the Netherlands and support its borderless product strategy using existing genetics, R&D, and product development investments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.91%
Tags
Rhea-AI Summary

Cronos (NASDAQ: CRON) launched Lord Jones Live Resin Fusions™ pre-rolls in Canada on November 25, 2025, expanding the Lord Jones premium cannabis portfolio.

Each 0.5g pre-roll pairs single-sourced dried flower with terpene-rich pure live resin caviar, targets 42%+ THC potency, and includes a reusable ceramic tip for a cooler smoke. New strains available at select Canadian retailers are Durban Kush x Citrus Sap, Hell Fire OG x Cali Gas, and Sour Diesel x Orange Velvet. More details and the full collection are available at lordjones.ca.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.82%
Tags
none
-
Rhea-AI Summary

Cronos Group (NASDAQ: CRON) reported Q3 2025 results with net revenue of $36.3M, up 6% year‑over‑year and 9% sequentially, driven by record sales in Israel where PEACE NATURALS is the top brand. Gross profit rose to $18.3M and Adjusted EBITDA was positive $5.7M. The company ended the quarter with an industry‑leading liquidity position of $824M in cash and short‑term investments. Spinach retained the #2 brand ranking in Canada and Lord Jones and PEACE NATURALS showed strong category positions. Cronos GrowCo expansion completed with new flower capacity coming online in Fall 2025; international ex‑Israel shipments were modest this quarter due to timing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.82%
Tags
none
-
Rhea-AI Summary

Cronos (NASDAQ: CRON) is reintroducing its limited-edition SOURZ by Spinach Caramel Green Apple flavor for the Fall and Halloween 2025 season. The rollout returns the original Caramel Green Apple 5-pack gummies and adds two new fall exclusives: a Fully Blasted Caramel Green Apple 10mg THC gummy and a Spinach Sweet Green Apple 1g Sativa vape infused with liquid diamonds.

The flavor first launched in Fall 2024; the seasonal products are available now across Canada. For product details and store availability, the company directs consumers to the Spinach website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.81%
Tags
none
Rhea-AI Summary

Cronos Group (NASDAQ: CRON) will hold its 2025 third quarter earnings conference call on Thursday, November 6, 2025 at 8:30 a.m. ET. Senior management will discuss the company’s financial results and take questions after prepared remarks.

Participants must register to attend the call or webcast at https://ir.thecronosgroup.com/events-presentations. The company recommends dialing in 15 minutes early to avoid delays. A webcast replay will be archived on the company website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.9%
Tags
conferences
-
Rhea-AI Summary

Cronos (NASDAQ: CRON) announced on October 9, 2025 that its SOURZ by Spinach Fully Blasted gummies will be sold in new multipack formats featuring liquid diamond‑infused gummies.

Products will launch in 5‑pack (5 x 10mg THC) and 10‑pack (10 x 10mg THC; one 10mg THC|10mg CBD SKU) configurations across five core flavors and will be available now in Alberta, British Columbia, Manitoba, Newfoundland, Nova Scotia, Ontario, Prince Edward Island, and Saskatchewan.

Management highlighted that SOURZ by Spinach holds just over 20% market share and has ranked as the #1 edible in Canada since September 2024, positioning the multipacks as a convenience and value play for existing customers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.12%
Tags
none
-
Rhea-AI Summary

Cronos Group (NASDAQ: CRON) reported strong Q2 2025 results with net revenue increasing 21% year-over-year to $33.5 million. The company achieved its highest-ever international and Israel revenue, with PEACE NATURALS® maintaining its position as the top cannabis brand in Israel.

Key financial metrics include gross profit of $14.5 million (up 130% YoY), improved gross margin to 43%, and Adjusted EBITDA of $1.7 million. The company maintains a strong balance sheet with $834 million in cash and short-term investments.

Notable developments include Spinach® ranking as Canada's second most popular cannabis brand with 4.7% market share, completion of the Cronos GrowCo expansion, and a strategic C$25.2 million investment in High Tide Inc. The company also successfully resolved the Israeli anti-dumping duty issue and expanded PEACE NATURALS® into new international markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.1%
Tags
none
Rhea-AI Summary

Cronos Group (NASDAQ: CRON) has scheduled its 2025 second quarter earnings conference call for Thursday, August 7, 2025 at 8:30 a.m. ET. The company's senior management will present financial results and conduct a Q&A session with the investment community.

Participants can register for the call and webcast through the company's investor relations website. To ensure timely participation, attendees are encouraged to dial in fifteen minutes before the scheduled start time. A replay of the webcast will be available on Cronos Group's website after the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.97%
Tags
conferences earnings

FAQ

What is the current stock price of Cronos Group (CRON)?

The current stock price of Cronos Group (CRON) is $2.69 as of June 23, 2026.

What is the market cap of Cronos Group (CRON)?

The market cap of Cronos Group (CRON) is approximately 1.0B.